Outputs Explained

After processing the inputs, the calculator provides several key values to guide dosing decisions:

• Ideal Body Weight (IBW): Calculated to ensure appropriate dosing, especially in underweight or obese patients. It's a crucial factor in the digoxin clearance formula.
• Creatinine Clearance (CrCl): An estimate of the patient's renal function, calculated using the Cockcroft-Gault equation. As digoxin is primarily cleared by the kidneys, this is a critical determinant of the maintenance dose.
• Digoxin Clearance (CLdig): The estimated rate at which digoxin is removed from the body, incorporating both renal (CrCl) and non-renal clearance pathways. The formula adjusts based on the presence of congestive heart failure.
• Calculated Maintenance Dose: The precise daily dose in micrograms (mcg) derived from the pharmacokinetic formula to achieve the target serum concentration.
• Recommended Practical Dose: The calculated dose rounded to the nearest available tablet strength (e.g., 62.5 mcg, 125 mcg, 250 mcg) to facilitate practical administration.

How to Use This Information

To effectively use the calculator and interpret its results, ensure the following patient data is accurately entered:

1. Patient Demographics: Age, sex, weight, and height are used to calculate IBW and CrCl.
2. Renal Function: Provide a recent serum creatinine (SCr) value. The tool can convert between mg/dL and µmol/L.
3. Clinical Condition: Specify if the patient has Congestive Heart Failure (CHF), as this alters the non-renal clearance component of the dosing formula.
4. Digoxin Formulation: Select the correct formulation (Tablet, Elixir, or IV) to apply the appropriate bioavailability (F) factor (0.7, 0.8, or 1.0, respectively).
5. Target Concentration: Input the desired steady-state serum digoxin concentration (SDC), typically 0.5-0.9 ng/mL for heart failure or 0.8-2.0 ng/mL for atrial fibrillation.
6. Drug Interactions: Select any concomitant medications known to significantly alter digoxin clearance, such as amiodarone or verapamil. The tool will automatically adjust the dose recommendation.

Dosing Overview

Digoxin has a narrow therapeutic index, meaning the margin between a therapeutic dose and a toxic dose is small. Dosing must be individualized based on patient-specific factors. The maintenance dose aims to replace the amount of digoxin eliminated by the body each day to maintain a steady therapeutic serum level.

The core principle is: Maintenance Dose = (Target SDC × Digoxin Clearance) / Bioavailability. The calculator automates this calculation, incorporating adjustments for clinical conditions and drug interactions to provide a reliable starting point for therapy.

Switching Formulations

When switching between different digoxin formulations (e.g., from intravenous to oral tablets), the dose must be adjusted to account for differences in bioavailability (F).

• IV to Oral: Since oral forms are less completely absorbed, the oral dose will need to be higher than the IV dose. The formula is: Oral Dose = IV Dose / F_oral. For example, switching from 100 mcg IV (F=1.0) to tablets (F=0.7) would require a dose of approximately 100 / 0.7 = 143 mcg. A practical dose of 125 mcg would likely be chosen.
• Oral to IV: The IV dose will be lower than the oral dose. The formula is: IV Dose = Oral Dose × F_oral.

Missed Dose

For a missed dose of digoxin, advise the patient to take it as soon as they remember. However, if it is almost time for the next scheduled dose (e.g., within 12 hours of the next dose for once-daily dosing), they should skip the missed dose and resume their regular dosing schedule. Patients should not take two doses at the same time to make up for a missed one.

Safety Alerts

Pay close attention to the following clinical scenarios which increase the risk of digoxin toxicity:

• Renal Impairment: Patients with a CrCl below 30 mL/min are at high risk of accumulation and toxicity. Doses should be conservative, and serum levels monitored closely.
• Elderly Patients: Patients over 75 may have reduced renal function even with a normal serum creatinine. Use caution and consider lower starting doses.
• Drug Interactions: Medications like amiodarone, dronedarone, quinidine, and verapamil can significantly increase digoxin levels by inhibiting P-glycoprotein. The calculator automatically suggests a dose reduction (30-50%), but close monitoring is still essential.
• Electrolyte Imbalances: Hypokalemia, hypomagnesemia, and hypercalcemia can increase the sensitivity of the myocardium to digoxin and precipitate arrhythmias, even with therapeutic serum levels.

Frequently Asked Questions (FAQ)

How does Congestive Heart Failure (CHF) affect the digoxin dose?

In patients with CHF, the non-renal clearance of digoxin is reduced. The calculator uses a modified formula for digoxin clearance (CLdig = (0.33 × IBW) + (0.9 × CrCl)) for CHF patients, which typically results in a lower recommended maintenance dose compared to non-CHF patients.

Why does the calculator use Ideal Body Weight (IBW)?

Digoxin distributes primarily into lean muscle tissue, not fat. Using IBW (or adjusted body weight in some models) for clearance calculations provides a more accurate estimate of the volume of distribution and subsequent dose requirements, preventing potential overdosing in obese patients.

What adjustment is made for a drug interaction with Amiodarone?

When Amiodarone is selected, the calculator automatically reduces the calculated maintenance dose by 50%. This is based on clinical evidence showing that amiodarone can double the serum concentration of digoxin.

What is the difference between the "Calculated Dose" and "Practical Dose"?

The "Calculated Dose" is the precise mathematical result from the pharmacokinetic formula. The "Practical Dose" is this result rounded to the nearest commercially available tablet strength (e.g., 62.5 mcg, 125 mcg), providing a dose that can be realistically administered.

Is this calculator suitable for calculating a loading dose?

No, this tool is specifically designed to calculate the daily maintenance dose. A loading dose, if required, must be calculated separately based on volume of distribution and desired peak concentration.

Why is a warning shown for low serum creatinine in the elderly?

In elderly patients, muscle mass can be low, leading to a low serum creatinine (e.g., <0.7 mg/dL) that may not accurately reflect their true renal function. This can cause the Cockcroft-Gault formula to overestimate CrCl. The calculator warns that rounding the SCr up to 0.8 or 1.0 mg/dL may provide a more conservative and safer dose estimate.

Can I use this calculator for pediatric patients?

No. The pharmacokinetic formulas (Cockcroft-Gault, digoxin clearance) used in this calculator are validated for adult populations only and are not appropriate for pediatric dosing.

What should I do if the recommended dose seems too high or low?

The calculator is a decision-support tool. Always apply clinical judgment. Double-check all input values for accuracy. If the result is unexpected, review the patient's full clinical picture, consider monitoring serum levels, and consult pharmacy or specialist resources.

References

1. LANOXIN (digoxin) Tablets - FDA Prescribing Information. U.S. Food and Drug Administration.
2. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of the American College of Cardiology.
3. Raina, H., & Kaur, G. (2020). Pharmacokinetic and Pharmacodynamic Drug Interactions of Digoxin with Allopathic and Herbal Drugs. Current Drug Metabolism, 21(7), 525–534. https://pubmed.ncbi.nlm.nih.gov/32410526/
4. Bauman, J. L., DiDomenico, R. J., & Galanter, W. L. (2016). Mechanisms, manifestations, and management of digoxin toxicity in the modern era. American journal of cardiovascular drugs, 16(5), 1–11.